Atlas Trials

Neurocognitive Outcome of Bilateral or Unilateral Hippocampal Avoidance WBRT With Memantine for Brain Metastases

Clinical trial NCT04801342 · UNKNOWN

Trial details

NCT number
NCT04801342
Sponsor
National Taiwan University Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Malignant Neoplasm to Brain
Start date
2021-04-01
Primary completion
2024-01-01
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.